Evaluation of Biofilm Formation and Prevalence of Multidrug-Resistant Strains of Staphylococcus epidermidis Isolated from Neonates with Sepsis in Southern Poland.
Iwona Skiba-KurekPaweł NowakJoanna EmpelMagdalena TomczakJoanna KlepackaIwona Sowa-SierantIwona ŻakBartosz PomiernyElżbieta KarczewskaPublished in: Pathogens (Basel, Switzerland) (2021)
Staphylococcus epidermidis strains play an important role in nosocomial infections, especially in the ones associated with biofilm formation on medical devices. The paper was aimed at analyzing the mechanisms of antibiotic resistance and confirming the biofilm-forming ability among S. epidermidis strains isolated from the blood of hospitalized newborns. Genetic analysis of resistance mechanism determinants included multiplex PCR detection of mecA, ermA, ermB, ermC, msrA, and mef genes. Biofilm analysis comprised phenotypic and genotypic methods including Christensen and Freeman methods and PCR detection of the icaADB gene complex. Among the tested S. epidermidis strains, 89% of the isolates were resistant to methicillin, 67%-to erythromycin, 53%-to clindamycin, 63%-to gentamicin, and 23%-to teicoplanin, while all the strains were susceptible to vancomycin and linezolid. The mecA gene was detected in 89% of the isolates, the ermC gene was the most common and present among 56% of the strains, while the msrA gene was observed in 11% isolates. Eighty-five percent of the strains were described as biofilm-positive by phenotypic methods and carried the icaADB gene cluster. Multidrug resistance and the biofilm-forming ability in most of the strains tested may contribute to antimicrobial therapy failure (p < 0.05).
Keyphrases
- biofilm formation
- escherichia coli
- staphylococcus aureus
- pseudomonas aeruginosa
- candida albicans
- genome wide
- copy number
- methicillin resistant staphylococcus aureus
- genome wide identification
- multidrug resistant
- klebsiella pneumoniae
- cystic fibrosis
- real time pcr
- acinetobacter baumannii
- dna methylation
- acute kidney injury
- stem cells
- gene expression
- preterm infants
- high throughput
- gram negative
- replacement therapy